`
`SIGN IN
`
`Articles
`
`Sresults (0.01 sec) @) Myprofile
`
`ye Mylibrary
`
`Any time
`Since 2018
`Since 2017
`Since 2014
`
`Custom range...
`
`Sort by relevance
`Sort by date
`
`¥ include citations
`
`Create alert
`
`Penetration enhancementof 8 2-selective agonist, tulobuterol, across hairless mouse
`skin
`
`Search within citing articles
`
`Recent advancesin transdermal drug delivery
`RK Subedi, SY Oh, MK Chun, HK Choi - Archives of pharmacal research, 2010 - Springer
`Abstract Transdermaldelivery of pharmacologically active agents has been extensively
`studied for the past 40 years. Despite the strong efforts, currently, only about 40 products are
`in market on about 20 drug molecules, due to the requirements that the patch area should
`Cited by 185 Related articles All 7 versions
`
`Influence of formulation variables in transdermal drug delivery system
`containing zolmitriptan
`RK Subedi, JP Ryoo, C Moon, HK Choi - International journal of ..., 2011 - Elsevier
`Abstract The effects of different formulation variables including pressure sensitive adhesive
`(PSA), thickness of the matrix, solvent system, inclusion of crystallization inhibitor, loading
`amount of drug and enhancers on the transdermal absorption of zolmitriptan were
`Cited by 25. Related articles All 7 versions
`
`Formulation and in vitro evaluation of transdermal drug delivery system for
`donepezil
`RK Subedi, JP Ryoo, C Moon, MK Chun... - Journal of Pharmaceutical ..., 2012 - Springer
`Abstract The effects of different formulation variables on the transdermal absorption of
`donepezil were investigated. The permeation of donepezil from various pressure sensitive
`adhesive matrices was evaluated using flow-through diffusion cell system at 37° C. The
`Cited by 8 Related articles All 5 versions
`
`Current pharmaceutical design on adhesive based
`transdermal drug delivery systems
`AGhosh,SBanerjee, S Kaity... - Current pharmaceutical ..., 2015 - ingentaconnect.com
`Drug-in-adhesive transdermal drug delivery matrix exploits intimate contact of the carrier
`with stratum corneum, the principal skin barrier to drug transport, to deliver the actives
`across the skin and into the systemic circulation. The main application challenges of drug-in-
`Cited by 4 Related articles All 6 versions
`
`[PDF] researchgate.net
`
`Patches containing tulobuterol
`S Shirai, M Yamaji, O Yoshimoto, M Naruse... - US Patent ..., 2011 - Google Patents
`A patch containing tulobuterol in the low concentration and having the stable release-
`controllability, prepared by laminating an adhesive layer consisting of a rubber, an adhesive
`resin and a plasticizer on a backing, wherein 1 to 4 w/w% oftulobuterolin the lower
`Related articles All 5 versions
`
`Help
`
`Privacy
`
`Terms
`
`Noven Pharmaceuticals, Inc.
`EX2014
`Mylan Tech., Inc. v. Noven Pharma., Inc.
`IPR2018-00173
`
`0001
`
`